GAS5 and ovarian cancer: Furthermore, the tumor-suppressing function of GAS5 was reported in esophageal squamous cell carcinoma [53], in cervical cancer through the miR-196a/miR-205/FOXO1 axis [54], and in ovarian cancer via the miR-196a/Homeobox 5 (HOXA5) axis [55].